CAMBRIDGE, Ont. — A luxury luggage manufacturer is laying off 149 workers at its plant in Cambridge, Ont.Rimowa, a German-based luggage maker, says the decision to cut the jobs was made to ensure the plant remains profitable.The company says it regrets the impact the layoffs will have on Cambridge residents.The Cambridge plant, established in 2008, was Rimowa’s first facility in North America.Rimowa said at the time that setting up shop in Canada was due to the skill of Canadian workers.Rimowa, which has production facilities in Germany, Czech Republic, Brazil and Canada, is known for its distinctive case shell luggage with shiny grooved sides.
Global engineering firm, DRA, has secured a contract with Exxaro Coal Mpumalanga (Pty) Ltd a subsidiary of JSE listed Exxaro Resources Ltd, to construct a 500 t/h coal handling and preparation plant in Mpumalanga, South Africa.The coal handling and preparation plant consists of primary and secondary sizing stations, overland conveyor, two 7500t silos, low gravity and high gravity Dense Medium Separation (DMS) modules, thickener circuit, filter plant, stacker conveyor. The plant will produce both a domestic and an export product.“We are excited to partner once again with such a prestigious organisation. The quality of our engineering designs in the earlier project phases as well as our competitive pricing and well-established reputation in coal projects ultimately secured us the work when Exxaro embarked on a campaign to develop one of their key coal assets in the Belfast area,” explains Alistair Hodgkinson, Senior Vice President at DRA.“This latest partnership allows DRA the opportunity to showcase our vast experience in successfully implementing large-scale coal projects and the added value we can offer our clients on any project,” says Hodgkinson.The project will commence in January 2018 and is expected to be completed in October 2019.“We look forward to the successful completion of this project and accompanying Exxaro on their development campaign in the area,” concludes Hodgkinson.